When it comes to prostate MRI, experience matters. Discover why choosing an expert with a proven track record can make all the difference in accurate, reliable results. keep reading
Let’s face it, guys. We’re not getting any younger. In fact, society is getting older. The Population Reference Bureau tells us that in the U.S, the number of those age 65 and up is expected to nearly double from 52 million in 2018 to 95 million by 2060... keep reading
Does PSA screening reduce PCa mortality, or doesn’t it? We know that PSA is not specific for cancer, since many prostate conditions can cause a rise in PSA blood levels. We also know that an elevated PSA can lead to a conventional TRUS-guided biopsy, and that such biopsies can either miss prostate cancer or... keep reading
Artificial Intelligence is transforming prostate MRI interpretation, making it faster and more precise. See how this breakthrough technology is elevating prostate health diagnostics. keep reading
Understanding erectile dysfunction can lead to better health and confidence. Discover five key facts about ED and how you can take control for a happier, healthier life. keep reading
The annual American Urological Society meeting (AUA 2015, May 15-19) has more presentations than ever on multiparametric MRI detection of prostate cancer, MRI targeted biopsies, MRI/ultrasound fusion, and MRI-guided focal therapies. The urologic world is sitting up and taking notice as advanced imaging is changing the prostate cancer landscape. I will be sharing selected presentations keep reading
By: Dan Sperling, MD Many focal laser ablation patients, and those considering this targeted prostate cancer treatment, are eagerly anticipating the May 15-19 American Urological Association meeting in New Orleans. Given that the majority of urologists are not exactly FLA-friendly, why would fans of our pioneering and elegant therapy set their sights on this meeting? keep reading
By: Dan Sperling, M.D. In 2009, an article on the single-cell theory of prostate cancer metastasis appeared in the journal Nature. There was little fanfare, but it might have been better met with a trumpeted announcement. Why? Because it supported the theory that some prostate cancer cells are more lethal than others—and this has tremendous keep reading
ASCO Connection is the official membership magazine of the American Society for Clinical Oncology (ASCO). In August 2014, the magazine carried an article by ASCO member Joel B. Nelson, MD (Chair of the Department of Urology at University of Pittsburgh). The title was “The Lack of Value for Robot-Assisted Radical Prostatectomy.”[i] Lack of value? That’s keep reading
One of the most respected U.S. urologists is Dr. E. David Crawford, Professor of Surgery, Urology, and Radiation Oncology, and head of the Section of Urologic Oncology at the University of Colorado Anschutz Medical Campus. He gave a presentation to the plenary session of the recent European Association of Urology meeting in Madrid, on the keep reading
The annual Genitourinary Cancers Symposium is a three day professional meeting on cancers related to the prostate, bladder, kidneys, and other organ systems related to urinary and sexual function. Prostate cancer has an entire poster section devoted just to this disease. At the Feb. 26-28, 2015 symposium on Orlando, one of the general presentation sessions keep reading
A frequent concern of patients who come to our Center for focal laser ablation is the risk of side effects from whole gland treatments. Men commonly tell me things like: “I don’t want surgery because I don’t want to wear diapers, even temporarily.” “I don’t think the urologist is telling me all the facts about keep reading
The Reverend Jesse Jackson described the American dream as one big tent: “And on that big tent you have four basic promises: equal protection under the law, equal opportunity, equal access, and fair share.” A new study suggests that when it comes to prostate cancer (PCa), patients do not have equal access to medical care. keep reading
Four thousand five hundred seventy-seven prostate cancer patients can’t be wrong. At least, a study in the Journal of the American Medical Association (JAMA) reported some interesting findings after tracking that many men with non-metastatic prostate cancer between 1986-2010. Those men who replaced 10% of their total daily calories from carbohydrates with healthy fats from keep reading
Four thousand five hundred seventy-seven prostate cancer patients can’t be wrong. At least, a study in the Journal of the American Medical Association (JAMA) reported some interesting findings after tracking that many men with non-metastatic prostate cancer between 1986-2010. Those men who replaced 10% of their total daily calories from carbohydrates with healthy fats from keep reading
